Insider Transactions in Q2 2017 at Vyant Bio, Inc. (VYNT)
Insider Transaction List (Q2 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2017
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
100,000
+3.78%
|
$300,000
$3.75 P/Share
|
|
Jun 07
2017
|
Michael J. Welsh Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+19.94%
|
-
|
|
Jun 07
2017
|
Franklyn G Prendergast Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+20.0%
|
-
|
|
Jun 07
2017
|
Raju S.K. Chaganti Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.74%
|
-
|
|
Jun 07
2017
|
Edmund Cannon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+13.59%
|
-
|
|
Jun 07
2017
|
John Pappajohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.1%
|
-
|
|
Jun 07
2017
|
Geoffrey E. Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+9.09%
|
-
|
|
Jun 07
2017
|
Howard Mc Leod Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+18.52%
|
-
|
|
May 25
2017
|
Igor Gitelman Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct |
937
+50.0%
|
$2,811
$3.95 P/Share
|
|
May 23
2017
|
Igor Gitelman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
937
-100.0%
|
$3,748
$4.02 P/Share
|
|
May 23
2017
|
Igor Gitelman Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
937
+50.0%
|
$1,874
$2.5 P/Share
|
|
May 16
2017
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
19,310
+0.79%
|
$57,930
$3.8 P/Share
|
|
May 16
2017
|
Geoffrey E. Harris Director |
BUY
Open market or private purchase
|
Direct |
2,500
+10.0%
|
$7,500
$3.75 P/Share
|